Voyager Therapeutics
VYGR
48 hedge funds and large institutions have $116M invested in Voyager Therapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 7
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
35% more capital invested
Capital invested by funds: $86.5M → $116M (+$29.9M)
12% more funds holding
Funds holding: 43 → 48 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.41M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.58M |
| 3 |
JP Morgan Chase
New York
|
+$2.23M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.91M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.2M |
| 2 |
Goldman Sachs
New York
|
-$1.33M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$514K |
| 4 |
CC
Casdin Capital
New York
|
-$206K |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$168K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,390 | Closed |
|
|
IA
52
IFP Advisors
Tampa,
Florida
| – | -$8K | -400 | Closed |
|
VYGR Hedge Fund Activity: Q2 2016 in Review
48 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2016, worth a combined $116M — up 35% from $86.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VYGR positions and 4 closed out — a net gain of 5 holders — while 28 added to existing stakes and 7 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $5.41M. The largest seller was Wellington Management Group, cutting an estimated $10.2M.
- 48 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2016, up from 43 in Q1 2016.
- Funds reported $116M of Voyager Therapeutics stock for Q2 2016, up 35% quarter-over-quarter.
- 9 funds opened new Voyager Therapeutics positions in Q2 2016 and 4 closed out, a net change of +5 holders.
- The largest Voyager Therapeutics buyer in Q2 2016 was PFM Health Sciences, an estimated $5.41M added.
- The largest Voyager Therapeutics seller in Q2 2016 was Wellington Management Group, an estimated $10.2M sold.
Based on aggregated 13F filings for Q2 2016.